ReviewsTropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
Under a Creative Commons license
open access
TRK
tropomyosin receptor kinase
NTRK gene fusions
TRK fusion cancer
Cited by (0)
- †
A. Amatu and A. Sartore-Bianchi contributed equally to this work.
- *
Dr Hyman discloses consulting or advisory roles with AstraZeneca, Bayer, Boehringer Ingelheim, Chugai Pharma, CytomX Therapeutics, Genentech and Pfizer, research funding from AstraZeneca, Bayer, Loxo Oncology and Puma Biotechnology, and travel, accommodation or expenses from Chugai Pharma and Genentech. Dr Ladanyi discloses research funding and advisory board compensation from Loxo Oncology, and advisory board compensation from Bayer. The guest editors received no honorarium for the preparation of this supplement.
Copyright © 2019 European Society for Medical Oncology. Published by Elsevier Ltd.